EnGen Bio announces positive results of a key challenge experiment toward the development of a universal flu vaccine
San Francisco, CA -- April 25, 2024 EnGen Bio LLC, a research-stage biotechnology company focused on a universal strategy for preventing and treating all Type A influenza strains, has announced the attainment of a key preclinical milestone in its research toward the…